Gary Walker is an Oncology physician affiliated with Banner MD Anderson Cancer Center. OpenAlex indexes 73 publications with 1,536 citations (h-index 18); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2946 E Banner Gateway Dr
Gilbert, AZ 852342165
Telephone
480-256-4500Provider last certified this registry record 28 Jan 2022.
Clinical trials
- A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS)
Sponsor: Recognify Life Sciences
Overall officialPhase 2CompletedNCT05686239 - Bimatoprost Ocular Insert Pharmacokinetic Study
Sponsor: ForSight Vision5, Inc.
Overall officialPhase 1CompletedNCT02444767 - Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems: CAPTURE
Sponsor: Abbott Medical Devices
Overall officialCompletedNCT00180492
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Siemens Medical Solutions USA, Inc.Program year20253 payments
- Siemens Medical Solutions USA, Inc.Program year20243 payments
- JAZZ PHARMACEUTICALS INC.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
59.3%Gabapentinoids59.3%Gabapentin100%Part D<11 patientsCardiovascular
40.7%Antiarrhythmic40.7%Lidocaine Hcl Viscous100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Ralf Metzger
Banner MD Anderson Cancer Center
Hung Khong, MD
Banner MD Anderson Cancer Center
Isaac Bowman, MD
Banner MD Anderson Cancer Center
Fade Mahmoud, MD
Banner MD Anderson Cancer Center
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”